Effects of Vitamin D and Omega-3 Fatty Acids Co-Supplementation on Inflammatory Biomarkers, Tumor Marker Cea, and Nutritional Status in Patients With Colorectal Cancer: A Study Protocol for a Double Blind Randomized Controlled Trial Publisher Pubmed



Haidari F¹ ; Abiri B² ; Iravani M³ ; Razavi SM⁴ ; Sarbakhsh P⁵ ; Ahmadiangali K⁶ ; Vafa M^{7, 8}
Source: Trials Published:2019

Abstract

Background: Much evidence is available demonstrating that both vitamin D and omega-3 fatty acids block the development and progression of colonic carcinogenesis. The results of animal studies have shown that the consumption of omega-3 fatty acids can decrease inflammatory biomarkers, enhance the efficacy of chemotherapy, and decrease the side effects of chemotherapy or cancer. Also, observational studies propose that higher levels of 25(OH)D are related to improved survival of colorectal cancer patients. This study will aim to evaluate the effects of vitamin D and omega-3 fatty acids co-supplementation on inflammatory biomarkers, tumor marker CEA, and nutritional status in colorectal cancer patients. Methods/design: We will carry out an 8-week double-blind randomized, placebo-controlled clinical trial to evaluate the effects of vitamin D and omega-3 fatty acids co-supplementation on inflammatory biomarkers, tumor marker CEA, and nutritional status in patients with stage O€O€ or O€O€O€ colorectal cancer undergoing chemotherapy. Discussion: Because of the important effects of vitamin D and omega-3 fatty acids on molecular pathways involved in cancer development and progression, it seems that both vitamin D and omega-3 fatty acids may provide a new adjuvant therapy by decreasing inflammatory biomarkers and resistance to cancer treatment in patients with colorectal cancer. © 2019 The Author(s).